Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

The Fourth Left Atrial Appendage Occlusion Study

NCT: NCT05963698 · RECRUITING

NCT IDNCT05963698
StatusRECRUITING
Start Date2023-11-30
Completion2029-12-01
SponsorHamilton Health Sciences Corporation (OTHER)
First posted
Last updated

Brief Summary

LAAOS-4 aims to determine if catheter-based endovascular left atrial appendage occlusion prevents ischemic stroke or systemic embolism in participants with atrial fibrillation, who remain at high risk of stroke, despite receiving ongoing treatment with oral anticoagulation.

Frequently Asked Questions

What is The Fourth Left Atrial Appendage Occlusion Study?

The Fourth Left Atrial Appendage Occlusion Study is a clinical trial registered under NCT05963698. Current status: RECRUITING.

What is the status of NCT05963698?

The current status of NCT05963698 (The Fourth Left Atrial Appendage Occlusion Study) is: RECRUITING.

When did The Fourth Left Atrial Appendage Occlusion Study start?

The Fourth Left Atrial Appendage Occlusion Study started on 2023-11-30.

Related Devices

K190884TigerPaw Pro Left Atrial Appendage Occlusion Fastener And Delivery ToolDatascope Corp. K252917ATLAAS (Atraumatic Left Atrial Appendage System) (AD)Genesee Biomedical, Inc.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑